Risk of bowel ischemia in patients with mesenteric neuroendocrine tumors after treatment with 177Lu-DOTATATE
Background: Lutetium-177 (177Lu)-DOTATATE is an effective treatment for metastatic gastroenteropancreatic (GEP) NETs. However, radiation can cause transient inflammation/swelling of tumors, which can result in toxicity. Treatment-related small bowel obstruction associated with mesenteric or peritone...
Saved in:
| Main Authors: | Eleonora Pelle, Taymeyah Al-Toubah, Ghassan El-Haddad, Brian Morse, Bhavana Konda, Vineeth Sukrithan, Jonathan Strosberg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2025-07-01
|
| Series: | Endocrine Oncology |
| Subjects: | |
| Online Access: | https://eo.bioscientifica.com/view/journals/eo/5/1/EO-25-0033.xml |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Imaging-derived biomarkers from 68Ga-DOTATOC PET/CT scans to predict survival of patients with neuroendocrine tumors after PRRT with 177Lu-DOTATATE
by: Stephan Raad, et al.
Published: (2025-07-01) -
The prospective multicenter observational study of acute mesenteric ischemia (AMeSI): the results of the Arkhangelsk center
by: T. N. Semenkova, et al.
Published: (2024-06-01) -
Inflamed Mesenteric Pseudocyst Associated with Meckel’s Diverticulitis: Cause or Consequence
by: Stefan Talev, et al.
Published: (2024-12-01) -
Difficulties in the Radiation Diagnosis of Acute Mesenteric Thrombosis in Patients with Chronic Critical Illness
by: O. A. Staroseltseva, et al.
Published: (2021-09-01) -
RM2 and DB15 analogues bearing [177Lu]Lu-DOTAGA via different linkers, as radiotherapeutics: a head-to-head comparative study
by: Panagiotis Kanellopoulos, et al.
Published: (2025-07-01)